Maxcyte (MXCT) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Maxcyte (MXCT) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.92 Bn | 220.85 Bn | 8.34 Bn | 371.00 Mn |
| 2 | Danaher | 144.67 Bn | 140.33 Bn | 3.61 Bn | 707.60 Mn |
| 3 | Agilent Technologies | 41.02 Bn | 39.26 Bn | 1.04 Bn | 283.00 Mn |
| 4 | Illumina | 31.29 Bn | 30.12 Bn | 770.00 Mn | 153.00 Mn |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn | 111.63 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 157.01 Mn |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn | 26.81 Mn |
| 8 | Repligen | 9.31 Bn | 8.29 Bn | 110.04 Mn | 56.64 Mn |
| 9 | 10x Genomics | 8.66 Bn | 8.10 Bn | 112.50 Mn | 129.98 Mn |
| 10 | Maxcyte | 132.99 Mn | 132.99 Mn | 5.60 Mn | 106.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.82 Mn |
| Mar 31, 2026 | 106.88 Mn |
| Dec 31, 2025 | 106.43 Mn |
| Sep 30, 2025 | 106.61 Mn |
| Jun 30, 2025 | 106.40 Mn |
| Mar 31, 2025 | 105.95 Mn |
| Dec 31, 2024 | 104.85 Mn |
| Sep 30, 2024 | 105.11 Mn |
| Jun 30, 2024 | 104.64 Mn |
| Mar 31, 2024 | 104.09 Mn |
| Dec 31, 2023 | 103.27 Mn |
| Sep 30, 2023 | 103.45 Mn |
| Jun 30, 2023 | 103.06 Mn |
| Mar 31, 2023 | 102.85 Mn |
| Dec 31, 2022 | 101.70 Mn |
| Sep 30, 2022 | 101.81 Mn |
| Jun 30, 2022 | 101.43 Mn |
| Mar 31, 2022 | 101.31 Mn |
| Dec 31, 2021 | 90.62 Mn |
| Sep 30, 2021 | 84.71 Mn |